Non-GMP synthesis of compounds for drug development
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201600066C
- Awardee
-
Alchem Laboratories Corporation UEI LD2KY6H7KMQ5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,792,559
Award facts
- Opportunity
-
- N02CM6700105 Solicitation number
- Non-GMP Synthesis of Compounds for Drug Development Award Notice · Posted Apr 1, 2016
- Synthesis of Non-GMP Compounds For Screening Award Notice · Posted Feb 25, 2016
- Contract value 46% obligated
-
- $4,484,609.45 Current, with exercised options
- $6,092,489.45 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Santa Fe, FL 32615, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$8,687 | |
| Other Administrative Action | $21,198 | |
| Supplemental Agreement for work within scope | -$19,290 | |
| Supplemental Agreement for work within scope | $627,585 | |
| Exercise an Option | $563,874 | |
| Exercise an Option | $549,643 | |
| Exercise an Option | $535,826 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $522,411 |
About this award
This is a $6,092,489.45 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH), to Alchem Laboratories Corporation, a small business manufacturer based in Alachua, Florida. The contract is for the non-GMP (non-good manufacturing practice) synthesis of compounds to support NCI's drug development efforts. The contract has a period of performance through September 19, 2021.
Alchem Laboratories is also the holder of several indefinite delivery vehicle (IDV) contracts with NCI and the National Institute of Allergy and Infectious Diseases (NIAID), another NIH agency, for the provision of a range of preclinical services including drug synthesis, formulation development, and animal studies to advance cancer and HIV/AIDS research. Additionally, Alchem has received a $474,451 grant from the Defense Threat Reduction Agency to develop small molecule inhibitors targeting the Venezuelan equine encephalitis virus.
Quick answers
Who was awarded contract HHSN261201600066C?
HHSN261201600066C was awarded to Alchem Laboratories Corporation by National Cancer Institute (National Institutes of Health) on September 20, 2016.
How much is contract HHSN261201600066C worth?
The government has obligated $2,792,559 on HHSN261201600066C. Its current value, with exercised options, is $4,484,609. Its potential value, with all options, is $6,092,489.
Was contract HHSN261201600066C competed?
The extent of competition for HHSN261201600066C was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award